Healthcare Services

Cardiac Mapping Market Growth Expected to Reach $3.4 Billion by 2030 with 6.4% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Cardiac Mapping Market Over The 2026–2030 Period?

The cardiac mapping market size has demonstrated significant growth in recent years. It is projected to expand from $2.47 billion in 2025 to $2.65 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. The market’s previous growth can be primarily attributed to the increasing prevalence of atrial fibrillation, the expansion of electrophysiology labs, the growing adoption of catheter-based interventions, the improved availability of cardiac mapping systems, and a rising demand for minimally invasive procedures.

The cardiac mapping market is anticipated to experience robust expansion over the coming years, reaching a valuation of $3.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is fueled by factors such as the increasing integration of AI-assisted mapping algorithms, the broadening of complex arrhythmia treatment options, rising investment in electrophysiology infrastructure, an escalating demand for precision-guided ablation, and the greater adoption of advanced visualization platforms. Significant trends expected during this period include the wider embrace of 3D cardiac mapping systems, an increase in the use of real-time electrophysiology mapping, stronger integration of mapping with ablation procedures, the expansion of non-contact mapping technologies, and an enhanced focus on procedural accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16643&type=smp

Which Major Factors Are Driving The Expansion Of The Cardiac Mapping Market?

The rising incidence of heart ailments is anticipated to drive the expansion of the cardiac mapping market in the future. Heart ailments encompass a range of medical conditions or illnesses impacting the heart’s structure and its ability to function, resulting in complications like irregular heart rhythms, myocardial infarctions, and cardiac insufficiency. The increasing number of heart conditions can be linked to elements such as inactive lifestyles, unhealthy eating patterns, and an increasing elderly demographic. Cardiac mapping assists in both diagnosing and managing heart ailments by accurately pinpointing electrical irregularities in the heart’s beat. For example, in August 2025, according to the National Institutes of Health, a US-based government agency, between 2025 and 2050, cardiovascular prevalence is projected to rise by 90%, mortality by 73%, and DALYs by 55%, with deaths increasing from 20.5 million to 35.6 million. Consequently, the widespread occurrence of heart ailments is fueling the growth of the cardiac mapping market.

How Is The Cardiac Mapping Market Segmented Across Key Categories?

The cardiac mapping market covered in this report is segmented –

1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems

2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications

3) By End-User: Hospitals And Clinics, Diagnostic Centers

Subsegments:

1) By Contact Cardiac Mapping Systems: Electrode-Based Mapping Systems, Catheter-Based Mapping Systems, Integrated Mapping And Ablation Systems, 3D Mapping Systems

2) By Non-Contact Cardiac Mapping Systems: Non-Contact Voltage Mapping Systems, Electrocardiographic Mapping Systems

How Are Trends Shaping The Direction Of The Cardiac Mapping Market?

Leading entities within the cardiac mapping market are concentrating on creating advanced solutions, particularly pulsed field ablation, to enhance the accuracy, security, and effectiveness of therapies for cardiac arrhythmias. Pulsed Field Ablation (PFA) is a non-thermal method for cardiac ablation, employing high-voltage, brief electrical pulses to induce microscopic pores in heart tissue cells through electroporation. This process precisely eliminates abnormal cardiac cells causing arrhythmias, concurrently ensuring minimal harm to adjacent healthy tissue. An illustrative example is Medtronic Plc, an Ireland-based technology firm, which secured FDA approval in October 2024 for its Affera™ Mapping and Ablation System and the accompanying Sphere-9 Catheter. This integrated system functions as an all-in-one, high-density mapping and pulsed field (PF) and radiofrequency (RF) ablation catheter, specifically engineered for addressing persistent atrial fibrillation (AFib) and cavotricuspid isthmus (CTI) dependent atrial flutter.

Who Are The Dominant Players Shaping The Cardiac Mapping Market Landscape?

Major companies operating in the cardiac mapping market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Koninklijke Philips N.V., GE Healthcare Technologies, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Lepu Medical Technology Co. Ltd., Acutus Medical Inc., Kardium Inc., BioSig Technologies Inc., Catheter Precision Inc., EP Solutions SA, CoreMap Inc., Navix Medical Ltd., EPmap-System, Stereotaxis Inc., CathVision ApS, Baylis Medical Company Inc.

Read the full cardiac mapping market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-mapping-global-market-report

Which Region Currently Holds The Largest Share Of The Cardiac Mapping Market?

North America was the largest region in the cardiac mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Mapping Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16643&type=smp

Browse Through More Reports Similar to the Global Cardiac Mapping Market 2026, By The Business Research Company

Transthyretin Amyloidosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/transthyretin-amyloidosis-treatment-global-market-report

Cardiac Biomarkers Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Ventricular Fibrillation Global Market Report

https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795